(PDF) At 15.9% of CAGR Neurology Devices Market Share Touch US$ 44,045.9 Million by the End of 2027 | Latest CMI Insights 2021

Some of the most commonly used neurology devices include neurointerventional devices, neurostimulation devices, cranial dopplers, electromyographs, implantable neurostimulators, neurosurgery surgical robots, and skull clamps.

The global neurology devices market is estimated to account for US$ 44,045.9 Mn in terms of value by the end of 2027.

*The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it.

Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-pdf/3889

Drivers:

Research and development of advanced nervous system science gadgets are driving the growth of the neurology devices market. For example, in March 2020, specialists at the Institute for Genomic Medicine at Columbia University Irving Medical Center revealed the advancement of improvement mode particle-based semiconductor intended to record the electrical action of neurons and to perform continuous estimations that help in distinguishing and checking neurological issues

Opportunities:

For players in the global neurology devices industry, the development of novel imaging software for neurological disorders is expected to provide lucrative growth opportunities. For example, Qynapse, a medical technology company based in France, obtained 510(k) clearance from the US Food and Drug Administration in February 2020 for its QyScore neurodegenerative disease imaging software.

“Limited Time Offer”

Buy This Research Study Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/3889

Restraints:

Product recalls are likely to stifle business expansion. The US Food and Drug Administration (FDA) issued a Class 1 recall for Zimmer Biomet's ROSA Brain system in November 2019, citing a software problem.

Key Takeaways:

The global neurology devices market was worth US$ 13,572.1 million in 2019 and is projected to hit US$ 44,045.9 million by 2027, with a CAGR of 15.9% from 2020 to 2027. Over the forecast period, the global neurology devices market is expected to expand due to increased R&D of new neurology devices.

In terms of size, the Neuro-stimulation Devices segment dominated the global neurology devices market in 2019, accounting for 71.4 percent of the market, followed by Interventional Neurology Devices and CSF Management Devices. The segment's growth will be fueled by the rising prevalence of neurological disorders.

Market Trends:

Key Players in the market are introducing nervous system science gadgets to help medical care frameworks during the Covid-19 pandemic. For example, in May 2020, BIONIK Laboratories Corp. launched an In Motion automated framework, used to help stroke survivors and those with other neurological conditions recover arm and hand movement

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/neurology-devices-market-3157

Key players in the market are focused on endorsement and dispatch of new gadgets to grow their item portfolio. For example, in February 2020, Avanos Medical, Inc. received the U.S. Food and Drug Administration (FDA) endorsement for its 80-Watt COOLIEF Radiofrequency (RF) framework for neurological injury methodology.

Competitive Landscape:

Key Players engaged in the neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, BIONIK Laboratories Corp., Integra LifeSciences Holdings Corporation, Johnson and Johnson, Magstim Co Ltd., Braintale SAS, Medtronic, plc. Abbott, Zimmer Biomet, Stryker Corporation, Helius Medical Technologies, Inc., Avanos Medical, Inc., W.L. Carnage and Associates, Inc., HeadsafeIP Pty Ltd., Cerus Endovascular Ltd., and Cyberonics, Inc.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/market-insight/neurology-devices-market-3889

Key Developments:

1. In May 2020, HeadsafeIP Pty Ltd., a held mind wellbeing innovation organization, received 510(k) leeway from the U.S. Food and Drug Administration (FDA) for its NUROCHEK framework for mind appraisal.

2. In April 2020, Cerus Endovascular Ltd. received CE Mark endorsement for its 021 Contour Neurovascular System, viable with more modest industrially accessible 021 microcatheters for the treatment of saccular intracranial aneurysms

Table of Content

Global Neurology Devices Market Research Report
Section 1: Global Neurology Devices Industry Overview
Section 2: Global Economic Impact on Neurology Devices Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Neurology Devices Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Neurology Devices Market Forecast

Other Exclusive Reports:

Global Medical Automation Market Analysis - https://www.medgadget.com/2021/07/medical-automation-market-high-cost-of-automation-equipment-and-lack-of-skilled-professionals-majorly-in-emerging-economies-are-the-key-restraining-factors-for-market-growth.html

Global Pipettes and Accessories Market Analysis - https://www.medgadget.com/2021/07/pipettes-and-accessories-market-to-discern-magnified-growth-of-4-0-cagr-during-2021-to-2026-with-industry-size-trends-growth-and-demand.html

Global Interspinous Process Decompression Devices Market Analysis - https://www.medgadget.com/2021/07/interspinous-process-decompression-devices-market-increasing-incidence-of-spinal-injuries-is-also-expected-to-boost-growth-of-market.html

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

This release was published on openPR.